Skip to main content
. 2021 Oct 14;6(4):e966. doi: 10.1097/PR9.0000000000000966

Table 2.

Characteristics of the test treatment (final analysis set).

Characteristic
Presence of aura in the test treatment, % (n/N) 31.9 (29/91)
Baseline pain severity in the test treatment, % (n/N)
 Mild 20.9 (19/91)
 Moderate 59.3 (54/91)
 Severe 19.8 (18/91)
Presence of baseline associated symptoms in the test treatment, % (n/N)
 Nausea or vomiting 45.1 (41/91)
 Photophobia 81.3 (74/91)
 Phonophobia 71.4 (65/91)
Baseline functional disability, % (n/N)
 No limitation 43.8 (32/73)
 Some limitation 41.1 (30/73)
 Moderate limitation 15.1 (11/73)
 Severe limitation 0 (0/73)
Time from headache onset, % (n/N), min
 0–30 73 (66/91)
 30–60 22 (20/91)
 60 or more 5 (5/91)

The number of observations analyzed vary by parameter because of missing values.